1-anilino-8-naphthalenesulfonate has been researched along with Angiogenesis, Pathologic in 6 studies
1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, R | 1 |
| Pan, D | 2 |
| Cai, X | 1 |
| Yang, X | 2 |
| Senpan, A | 2 |
| Allen, JS | 2 |
| Lanza, GM | 2 |
| Wang, LV | 1 |
| Hall, JC | 1 |
| Marlow, LA | 1 |
| Mathias, AC | 1 |
| Dawson, LK | 1 |
| Durham, WF | 1 |
| Meshaw, KA | 1 |
| Mullin, RJ | 1 |
| Synnott, AJ | 1 |
| Small, DL | 1 |
| Krishna, M | 1 |
| von Hoff, D | 1 |
| Schüler, J | 1 |
| Hart, SN | 1 |
| Couch, FJ | 1 |
| Colon-Otero, G | 1 |
| Copland, JA | 1 |
| Sanyal, N | 1 |
| Schmieder, AH | 1 |
| Kim, B | 1 |
| Hu, G | 1 |
| Gross, RW | 1 |
| Wickline, SA | 1 |
| Araújo, FA | 1 |
| Rocha, MA | 1 |
| Capettini, LS | 1 |
| Campos, PP | 1 |
| Ferreira, MA | 1 |
| Lemos, VS | 1 |
| Andrade, SP | 1 |
| Zambon, A | 1 |
| Puato, M | 1 |
| Faggin, E | 1 |
| Bertocco, S | 1 |
| Vitturi, N | 1 |
| Polentarutti, V | 1 |
| Deriu, GP | 1 |
| Grego, F | 1 |
| Bertipaglia, B | 1 |
| Rattazzi, M | 1 |
| Vianello, D | 1 |
| Deeb, SS | 1 |
| Pauletto, P | 1 |
| Chiarugi, V | 1 |
| Ruggiero, M | 1 |
| Porciatti, F | 1 |
| Vannucchi, S | 1 |
| Ziche, M | 1 |
1 review available for 1-anilino-8-naphthalenesulfonate and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Cooperation of heparin with other angiogenetic effectors.
Topics: Adenosine Diphosphate; Blood Vessels; Capillaries; Cell Membrane; Copper; Epoprostenol; Heparin; His | 1986 |
5 other studies available for 1-anilino-8-naphthalenesulfonate and Angiogenesis, Pathologic
| Article | Year |
|---|---|
alphaVbeta3-targeted copper nanoparticles incorporating an Sn 2 lipase-labile fumagillin prodrug for photoacoustic neovascular imaging and treatment.
Topics: Angiogenesis Inhibitors; Animals; Copper; Cyclohexanes; Disease Models, Animal; Fatty Acids, Unsatur | 2015 |
Novel patient-derived xenograft mouse model for pancreatic acinar cell carcinoma demonstrates single agent activity of oxaliplatin.
Topics: Animals; Apoptosis; BRCA2 Protein; Carcinoma, Acinar Cell; Cell Proliferation; Cell Shape; Endpoint | 2016 |
Antiangiogenic nanotherapy with lipase-labile Sn-2 fumagillin prodrug.
Topics: Animals; Biological Availability; Cells, Cultured; Cyclohexanes; Fatty Acids, Unsaturated; Humans; L | 2012 |
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (fluvastatin) decreases inflammatory angiogenesis in mice.
Topics: Acetylglucosaminidase; Animals; Chemokine CCL2; Cholesterol; Fatty Acids, Monounsaturated; Fluvastat | 2013 |
Common hepatic lipase gene promoter variant predicts the degree of neointima formation after carotid endarterectomy: impact of plaque composition and lipoprotein phenotype.
Topics: Carotid Stenosis; DNA; Endarterectomy, Carotid; Follow-Up Studies; Humans; Immunohistochemistry; Lip | 2006 |